GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Masimo Corp (NAS:MASI) » Definitions » 10-Year RORE %

Masimo (Masimo) 10-Year RORE % : 0.73% (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Masimo 10-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Masimo's 10-Year RORE % for the quarter that ended in Dec. 2023 was 0.73%.

The industry rank for Masimo's 10-Year RORE % or its related term are showing as below:

MASI's 10-Year RORE % is ranked worse than
52.28% of 394 companies
in the Medical Devices & Instruments industry
Industry Median: 2.48 vs MASI: 0.73

Masimo 10-Year RORE % Historical Data

The historical data trend for Masimo's 10-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Masimo 10-Year RORE % Chart

Masimo Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
10-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.11 12.36 10.42 5.37 0.73

Masimo Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
10-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.37 3.55 3.62 1.93 0.73

Competitive Comparison of Masimo's 10-Year RORE %

For the Medical Devices subindustry, Masimo's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Masimo's 10-Year RORE % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Masimo's 10-Year RORE % distribution charts can be found below:

* The bar in red indicates where Masimo's 10-Year RORE % falls into.



Masimo 10-Year RORE % Calculation

Masimo's 10-Year RORE % for the quarter that ended in Dec. 2023 is calculated as:

10-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 10-year -Cumulative Dividends per Share for 10-year )
=( 1.51-1.29 )/( 29.94-0 )
=0.22/29.94
=0.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2023 and 10-year before.


Masimo  (NAS:MASI) 10-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Masimo 10-Year RORE % Related Terms

Thank you for viewing the detailed overview of Masimo's 10-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Masimo (Masimo) Business Description

Traded in Other Exchanges
Address
52 Discovery, Irvine, CA, USA, 92618
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
Executives
Rolf A Classon director C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Politan Capital Management Gp Llc other: Director by deputization 106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Politan Capital Partners Gp Llc other: Director by deputization 106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Quentin Koffey other: Director by deputization POLITAN CAPITAL MANAGEMENT LP, 106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Politan Capital Management Lp other: Director by deputization 106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Michelle Brennan director 1855 S. GRANT STREET, SAN MATEO CA 94402
Joe E Kiani director, officer: CEO and Chairman of the Board 4320 FOREST PARK AVENUE, SUITE 100, ST. LOUIS MO 63108
Paul Hataishi officer: SVP, Chief Accounting Officer C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Blair Tripodi officer: COO, Consumer Division C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Kevin P Duffy officer: President, Consumer 1 VIPER WAY, VISTA CA 92081
Adam Mikkelson director C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Tao Levy officer: EVP BUS DEV C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Micah W Young officer: EVP & Chief Financial Officer C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Thomas Samuel Mcclenahan officer: EVP & GENERAL COUNSEL 40 PARKER, IRVINE CA 92618
Craig B Reynolds director 1046 MIDDLEBROOK WAY, KENESAW GA 30144

Masimo (Masimo) Headlines

From GuruFocus